Evidence map›Paper›PMID 23604482›Full record

ReviewHandbook of experimental pharmacology2013

Molecular clocks in pharmacology.

Erik S Musiek, Garret A Fitzgerald

Open access · greenAbstract readReview
In one paragraph

Review in Handbook of experimental pharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Sleep disorders as risk factors for calcific aortic stenosis.American journal of preventive cardiology · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Factors Determining Plasticity of Responses to Drugs.International journal of molecular sciences · 2022
    Review
  10. Review
  11. The Brain's Reward System in Health and Disease.Advances in experimental medicine and biology · 2021
    Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Circadian hormone control in a human-on-a-chip: In vitro biology's ignored component?Experimental biology and medicine (Maywood, N.J.) · 2017
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Erik S MusiekDepartment of Neurology, Washington University School of Medicine, 7401 Byron Pl., Saint Louis, MO 63105, USA.
Garret A Fitzgerald
Translational Therapeutics (United States) · USWashington University in St. Louis · US

Funding

CIRCADIAN CLOCK DYSFUNCTION AS A MEDIATOR OF NEURODEGENERATIONK08NS079405 · NINDS · WASHINGTON UNIVERSITY · PI MUSIEK, ERIK STEVEN · 2012 to 2016
$844k
NINDS NIH HHS K08 NS079405
6 · The paper itself

Abstract

Circadian rhythms regulate a vast array of biological processes and play a fundamental role in mammalian physiology. As a result, considerable diurnal variation in the pharmacokinetics, efficacy, and side effect profiles of many therapeutics has been described. This variation has subsequently been tied to diurnal rhythms in absorption, distribution, metabolism, and excretion, as well as in pharmacodynamic variables, such as target expression. More recently, the molecular basis of circadian rhythmicity has been elucidated with the identification of clock genes, which oscillate in a circadian manner in most cells and tissues and regulate transcription of large sets of genes. Ongoing research efforts are beginning to reveal the critical role of circadian clock genes in the regulation of pharmacologic parameters, as well as the reciprocal impact of drugs on circadian clock function. This chapter will review the role of circadian clocks in the pharmacokinetics and pharmacodynamics of drug response and provide several examples of the complex regulation of pharmacologic systems by components of the molecular circadian clock.

Indexed as

PharmacokineticsAnimalsCircadian ClocksCircadian RhythmHumansMetabolic DiseasesPharmacology

Identifiers

PMID23604482
PMCPMC3684693
OpenAlexW75001224

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.